The technology accurately detects the presence of these gene fusions in acute promyelocytic leukemia ... Radon, Even at Levels Below EPA Guideline for Mitigation, Is Linked to Childhood Leukemia ...

PeCan-Seq enables sensitive, non-invasive ctDNA analysis for pediatric cancers, with high accuracy for hematologic ...

The FDA approved obecabtagene autoleucel for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia.

researchers at Case Western Reserve University are investigating a new approach to treat Acute Myeloid Leukemia (AML) in military Veterans. A new study finds that preschool-aged children with ...

Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than ...

On the other hand, for over a decade, multiparameter flow cytometry (MFC) has proven its value as a complementary ... chronic myelomonocytic leukemia (CMML) and in reactive/inflammatory conditions.

Exactly three years after an initial FDA green light for the third-line treatment of leukemia, Novartis’ Scemblix has won an accelerated approval to treat newly diagnosed patients. Tuesday ...

Jylamvo is now approved for pediatric acute lymphoblastic leukemia and juvenile idiopathic arthritis, offering a liquid methotrexate formulation. The formulation is stable at room temperature for 90 ...

For children with acute lymphoblastic leukemia (ALL), measurable residual disease (MRD) after the end of first consolidation (EOC) can be used to predict the need for subsequent MRD measurements ...

Acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) are cancers that originate from a type of white blood cell. AML features a rapid onset, and CML is slower to progress. Leukemia is a ...